NRC Health PE ratio NRC

Share price divided by earnings per share over the last twelve months, since 2013.

Today, Oct 23, 2026: 87.7×
10-year median: 35.1×
Against its 10-year history: 100th; percentile: 0 is its lowest day, 100 its highest
10-year range: 10.0× to 88.8×
Peer median: 34.2×

NRC Health's PE ratio is 87.7× as of Oct 23, 2026: a share price of $21.93 against $0.25 of earnings per share over the last twelve months.

That is above its ten-year median of 35.1×, higher than on 100% of days in the last ten years.

Over that time it ranged from 10.0× in Apr 2025 to 88.8× in Aug 2026.

The median for 3 diagnostics and research stocks of a similar size is 34.2×.

PE ratio over time

median 35.1×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	87.7×	17.3×	88.8×
2025	26.7×	10.0×	26.7×
2024	15.4×	14.8×	34.6×
2023	34.1×	29.1×	39.8×
2022	27.0×	22.5×	29.8×
2021	29.4×	29.2×	39.1×
2020	29.1×	29.1×	56.2×
2019	54.2×	37.2×	55.4×
2018	37.9×	37.6×	59.6×
2017	58.3×	28.2×	58.3×
2016	30.6×	21.9×	32.1×
2015	34.1×	24.9×	35.6×
2014	26.9×	10.6×	33.2×
2013	13.6×	6.1×	13.7×

Against its peers

Companies in Medical - Diagnostics & Research nearest NRC Health's size, closest first, today.

Company	PE ratio
NRCNRC Health	87.7×
ICCCImmucell	128×
CDNACareDx	33.4×
VCYTVeracyte	34.2×
Peer median	34.2×

Where NRC Health ranks

#17of 20Diagnostics and research stocks with the lowest PE ratio

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on NRC Health

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.